Cyclect congratulates Pfizer on receiving the 2024 ISPE Facility of the Year Award (FOYA) in the Operations and Project Execution category, recognising the Pfizer API Facility Extension project at Tuas 2 in Singapore.
The ISPE FOYA is the pharmaceutical manufacturing industry’s most prestigious project recognition, awarded by the International Society for Pharmaceutical Engineering to facilities that demonstrate outstanding achievement in design, construction, and operational performance.
Cyclect served as the General Electrical and Instrumentation (GE&I) contractor for the Tuas 2 project, delivering turnkey electrical installation, instrumentation, automation systems, and equipment hookups across the project lifecycle. The Pfizer Tuas 2 engagement is part of a multi-year, multi-project relationship in which Cyclect has served as Pfizer’s GE&I partner across successive capital projects at its Singapore pharmaceutical manufacturing facilities.
The FOYA recognition provides documented confirmation that the facility meets the pharmaceutical industry’s highest benchmarks for engineering execution and operational capability — and serves as a direct reference point for Cyclect’s pharmaceutical capital project credentials from one of the world’s leading biopharma companies.